Literature DB >> 2451256

Dyskinesia, antipsychotic-drug exposure and risk factors in a developmentally-disabled population.

R K Stone1, W F Alvarez, J E May.   

Abstract

The relation between antipsychotic drug (APD) exposure and the prevalence of dyskinesia (DK) was examined in a large, developmentally-disabled (DD) population. Using qualitative data in a cross-sectional, retrospective design, the drug-exposed group was systematically compared with a non-drug-exposed group, controlling for age and gender. When the population was evaluated with no regard to APD-exposure, age and female gender were significant risk factors, as in many prior studies. When APD-exposure was considered, it proved to be a complex variable dependent on the recency of exposure to APD, and the outcome depended on the method of analysis: when APD-exposure was considered as a binomial variable (yes/no), the relationship between APD and DK was not significant; when APD-exposure was controlled for recency of exposure, however, a significant relationship between APD and DK was demonstrated (p less than 0.01) although the relationship accounted for less than 3% of the variance. Analysis of the relation between DK-prevalence and recency-of-APD-exposure revealed a pattern of diminished prevalence during APD use and increased prevalence during early withdrawal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451256     DOI: 10.1016/0091-3057(88)90271-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

Review 1.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Tardive dyskinesia and pregnancy and delivery complications.

Authors:  M H El-DeFrawi; G Hirsch; A Jurkowicz; T J Craig
Journal:  Child Psychiatry Hum Dev       Date:  1996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.